Tous les communiqués | WebDisclosure

COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 14:00, il y a 10 mois 27 jours

GBC AG initiates coverage on dynaCERT Inc. – Buy recommendation with a price target of CAD 0.75 (EUR 0.48)
GBC AG initiates coverage on dynaCERT Inc., a Canadian cleantech company, issuing a Buy recommendation with a price target of CAD 0.75 (EUR 0.48). The company has developed HydraGEN™, a solution for reducing CO₂ emissions and improving fuel efficiency in diesel engines

Buy Recommendation GBC AG Cleantech DynaCERT Inc. HydraGEN
COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 14:00, il y a 10 mois 27 jours

O’KEY GROUP SHAREHOLDERS APPROVE REDOMICILIATION TO RUSSIA
O'KEY Group shareholders approve redomiciliation from Luxembourg to Russia. Company to move operations to the Kaliningrad region, maintaining business as usual. Investors to be regularly updated on the process

Shareholders Investors O'KEY Group Redomiciliation Kaliningrad Region
COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 13:30, il y a 10 mois 27 jours

ACCESS Newswire Reports Fourth Quarter and Full Year 2024 Results
ACCESS Newswire Inc. reports Q4 2024 results with a 1% revenue increase to $5.8M and adjusted EBITDA of $871K. Focus on communications business

Adjusted EBITDA Revenue Increase Q4 2024 Results ACCESS Newswire Inc. Communications Business
COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 13:30, il y a 10 mois 27 jours

Loar Holdings Inc. Announces Date and Time for Fourth Quarter and Full Year 2024 Earnings Conference Call
Loar Holdings Inc. to report Q4 2024 and Full Year 2024 earnings on March 31, 2025. Conference call at 10:30 a.m. ET. Webcast available. Company info & contact details provided

Conference Call Earnings Report Webcast Loar Holdings Inc. Q4 2024
COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 13:30, il y a 10 mois 27 jours

Xebra Brands Evaluates Strategic Opportunities Following Award of Dutch Cannabis License
Xebra Brands Ltd. obtains exclusive Dutch cannabis cultivation license for scientific research from the Minister of Health, focusing on strategic business opportunities and partnerships in Europe

Cannabis Cultivation Xebra Brands Ltd. Business Opportunities Dutch License European Partnerships
COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 13:21, il y a 10 mois 27 jours

ABO Energy wins further tariffs in wind tender
ABO Energy secures three more wind project tariffs in German Federal Network Agency's tender, continuing success streak

Renewable Energy Wind Projects Tender Tariffs ABO Energy
COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 13:19, il y a 10 mois 27 jours

Dalata Hotel Group PLC: HOL-Holding(s) in Company*
JPMorgan Chase & Co. notifies acquisition of 4.56% voting rights in Dalata Hotel Group PLC. Threshold of 4% crossed on 21st March 2025

Acquisition Voting Rights Notification Dalata Hotel Group JPMorgan Chase
COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 13:19, il y a 10 mois 27 jours

FORVIA TO OFFER USD 500 MILLION OF SENIOR NOTES
FORVIA to offer USD 500 million of senior notes due 2030 to repay existing indebtedness. Further issuance planned to repay long-term financial liabilities. Read more about FORVIA's financial strategy and goals

Financial Strategy USD 500 Million Senior Notes Forvia Indebtedness
COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 13:19, il y a 10 mois 27 jours

FORVIA PROPOSE L’ÉMISSION DE 500 MILLIONS DE DOLLARS AMÉRICAINS D’OBLIGATIONS SENIOR
FORVIA propose l'émission de 500 millions de dollars américains d'obligations senior à échéance 2030 pour rembourser sa dette existante. Opération suivant une émission d'obligations senior en euros en 2025

Dette Obligations Émission Forvia Senior
COMMUNIQUÉ DE PRESSE

publié le 25/03/2025 à 13:00, il y a 10 mois 27 jours

Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
Ainnova and Avant Technologies develop Vision AI platform for diabetic retinopathy early detection. Ainnova preparing for FDA pre-submission meeting to clear technology for the market

FDA Vision AI Platform Ainnova Avant Technologies Diabetic Retinopathy

Publié le 20/02/2026 à 19:29, il y a 1 jour 5 heures

SFPI GROUP: Liquidity agreement report S2 2025
Publié le 20/02/2026 à 19:29, il y a 1 jour 5 heures

SFPI GROUP: bilan du contrat de liquidité S2 S025
Publié le 20/02/2026 à 18:00, il y a 1 jour 6 heures

TERACT - Termination of liquidity agreement
Publié le 20/02/2026 à 18:00, il y a 1 jour 6 heures

TERACT - Résiliation du contrat de liquidité
Publié le 20/02/2026 à 17:35, il y a 1 jour 7 heures

CHIFFRE D'AFFAIRES 2025

Voir tout LES ECHOS COMFI WIRE

Publié le 21/02/2026 à 00:45, il y a 23 heures 59 minutes

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Publié le 21/02/2026 à 00:30, il y a 1 jour

Redwood AI Corp. Announces Engagement for IR Services
Publié le 20/02/2026 à 23:15, il y a 1 jour 1 heure

DigiPower X Announces Closing of Settlement
Publié le 20/02/2026 à 23:00, il y a 1 jour 1 heure

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Publié le 20/02/2026 à 22:17, il y a 1 jour 2 heures

Organto Foods Completes Warrant Exercise Incentive Program

Voir tout ACCESSWIRE

Publié le 21/02/2026 à 12:00, il y a 12 heures 44 minutes

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Publié le 21/02/2026 à 12:00, il y a 12 heures 44 minutes

Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Publié le 20/02/2026 à 18:36, il y a 1 jour 6 heures

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Publié le 20/02/2026 à 18:31, il y a 1 jour 6 heures

Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 20/02/2026 à 18:23, il y a 1 jour 6 heures

POS-Transaction in Own Shares

Voir tout EQS

News